Perspective Therapeutics, Inc.
Company Stats
- Market Cap
- $313.9M
- as of Sep 30, 2026
- Shares Outstanding
- 114.2M
- Free Float
- 60.1%
Income Statement
- Operating Income
- -$113.6M
- Net Income
- -$103.1M
- EBITDA
- -$110.3M
Cash Flow
- Free Cash Flow
- -$95.2M
- FCF Yield
- -30.3%
- Owner FCF Yield
- -33.2%
Balance Sheet
- Cash & Equivalents
- $30.6M
Returns & Capital
- SBC, 3Y Avg
- $6.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$95.2M | — |
| FY2024 | — | -$72.7M | — |
| FY2023 | $1.4M | -$38.0M | -2648.9% |
| FY2022 | $0 | -$10.7M | — |
| FY2022 | $10.8M | -$8.0M | -73.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 21, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back